Michael Barbella, Managing Editor05.27.22
Australia's breast implant market should grow steadily in the near future, as the country has recently taken steps to improve the procedure for patients.
New guidelines for managing breast implant surgeries are designed to protect patients from risks due to perilous practices and "carelessly performed" procedures. This initiative is expected to drive the breast implant market in the country, according to GlobalData.
GlobalData’s report, "Aesthetic Implants Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030," indicates the breast implants market accounted for around 85 percent of Australia’s aesthetic implants market in 2021.
With the implementation of new guidelines published by the New South Wales Ministry of Health, it will be made mandatory for doctors to follow certain standards of care while and after performing the breast implant surgery.
“The guidelines clearly state how doctors or medical professionals should perform their work while being transparent about the breast implant procedure, side effects, or any other risks associated with the procedure and the patients," said Anusha Kaushik, a medical devices analyst at GlobalData. "Discussing the available treatment options and the associated risks will help patients to take the best possible decision about their health.”
Along with the newly released guidelines, increase in the number of breast reconstruction and augmentation procedures are expected to boost Australia’s breast implant market in the coming years.
“These new guidelines, though tough for some surgeons to follow, are aimed at changing the way breast implant procedures are managed. This is expected to further drive the breast implants market in Australia by improving transparency and enhancing patient safety. However, the need for more specialized training and increase in the overhead costs these procedures may hamper the growth of this market,” Kaushik said.
New guidelines for managing breast implant surgeries are designed to protect patients from risks due to perilous practices and "carelessly performed" procedures. This initiative is expected to drive the breast implant market in the country, according to GlobalData.
GlobalData’s report, "Aesthetic Implants Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030," indicates the breast implants market accounted for around 85 percent of Australia’s aesthetic implants market in 2021.
With the implementation of new guidelines published by the New South Wales Ministry of Health, it will be made mandatory for doctors to follow certain standards of care while and after performing the breast implant surgery.
“The guidelines clearly state how doctors or medical professionals should perform their work while being transparent about the breast implant procedure, side effects, or any other risks associated with the procedure and the patients," said Anusha Kaushik, a medical devices analyst at GlobalData. "Discussing the available treatment options and the associated risks will help patients to take the best possible decision about their health.”
Along with the newly released guidelines, increase in the number of breast reconstruction and augmentation procedures are expected to boost Australia’s breast implant market in the coming years.
“These new guidelines, though tough for some surgeons to follow, are aimed at changing the way breast implant procedures are managed. This is expected to further drive the breast implants market in Australia by improving transparency and enhancing patient safety. However, the need for more specialized training and increase in the overhead costs these procedures may hamper the growth of this market,” Kaushik said.